Peptic ulcer disease (PUD) questions are Step bread-and-butter because they force you to integrate pathophysiology (acid vs mucosal defense) with risk factors (NSAIDs, H. pylori) and complications (bleeding, perforation, obstruction, malignancy)—and then not get baited by plausible distractors. Let’s run a classic Q-bank vignette and break down why every answer choice matters.
Tag: GI > Esophageal & Gastric Disorders
The Vignette (Classic Q-bank Style)
A 52-year-old man presents with burning epigastric pain for 2 months. The pain is worse between meals and at night and improves with food and antacids. He has been taking ibuprofen daily for knee pain. He reports dark, tarry stools over the past 2 days. Vitals are stable. Exam shows mild epigastric tenderness. Labs show Hgb 10.8 g/dL (low).
Upper endoscopy reveals a 1.5-cm ulcer in the first portion of the duodenum with a clean base and no active bleeding.
Question: What is the most appropriate next step in management?
Answer choices
A. Start IV octreotide
B. Start clarithromycin + amoxicillin + PPI
C. Start high-dose PPI and schedule repeat endoscopy in 8 weeks to rule out gastric cancer
D. Stop NSAIDs and start a proton pump inhibitor
E. Measure fasting serum gastrin level
The Correct Answer: D. Stop NSAIDs and start a proton pump inhibitor
This patient has duodenal ulcer disease with an upper GI bleed history (melena + anemia), and a major risk factor: daily NSAID use.
Why this is correct
- NSAIDs inhibit COX → ↓ prostaglandins (especially PGE₂)
→ ↓ mucus/bicarbonate secretion + ↓ mucosal blood flow + impaired epithelial repair
→ mucosal vulnerability to acid → ulcer formation. - For a duodenal ulcer, first-pass management includes:
- Stop the offending agent (NSAIDs)
- Acid suppression (PPI) to allow healing
High-yield PUD localization clues
| Feature | Duodenal ulcer | Gastric ulcer |
|---|---|---|
| Pain timing | Better with meals, worse later | Worse with meals |
| Weight | May gain | May lose |
| Malignancy risk | Rare | Must rule out malignancy |
| Major causes | H. pylori, NSAIDs | NSAIDs, H. pylori |
Important nuance: The question doesn’t explicitly tell you his H. pylori status. In real testing, you’re expected to treat H. pylori if present, but you should not assume it unless the stem provides a clue (positive test, chronic dyspepsia with no NSAIDs, etc.). With a clear NSAID precipitant, “stop NSAIDs + PPI” is the best next step.
Why the Other Answer Choices Are Wrong (and What They’re Testing)
A. Start IV octreotide
Why it’s tempting: “Melena” can trigger reflex treatment for GI bleeding.
Why it’s wrong: Octreotide is for variceal bleeding (portal HTN), not uncomplicated PUD.
- Variceal bleed clues: cirrhosis, ascites, spider angiomas, hematemesis, hypotension.
- PUD bleed management is typically PPI, endoscopic therapy if high-risk stigmata, transfusion if unstable.
USMLE hook:
- Octreotide + endoscopic banding → esophageal varices
- Ceftriaxone prophylaxis often accompanies variceal bleed management
B. Start clarithromycin + amoxicillin + PPI
Why it’s tempting: This is classic triple therapy for H. pylori.
Why it’s wrong (in this stem): You don’t have evidence of H. pylori infection yet, and he has a strong NSAID trigger. Also, clarithromycin-based triple therapy is less favored in many areas due to resistance.
High-yield H. pylori facts
- Most common cause of duodenal ulcers overall
- Virulence: urease, CagA (inflammation), VacA (cell injury)
- Association: gastric adenocarcinoma and MALT lymphoma
- Diagnosis: urea breath test, stool antigen, biopsy urease test
- Hold PPI 1–2 weeks before breath/stool testing to avoid false negatives.
- Treatment (common modern approach): bismuth quadruple therapy
- PPI + bismuth + tetracycline + metronidazole
What this distractor tests: Don’t “autopilot” into antibiotics without the testable setup.
C. Start high-dose PPI and schedule repeat endoscopy in 8 weeks to rule out gastric cancer
Why it’s tempting: Repeat endoscopy is a real thing.
Why it’s wrong: The ulcer is duodenal, and duodenal ulcers are very unlikely malignant. The “repeat endoscopy to rule out cancer” move is for gastric ulcers, especially if:
- ulcer looks suspicious (irregular margins, mass-like lesion)
- persistent symptoms despite therapy
- risk factors (older age, weight loss, early satiety, anemia out of proportion)
High-yield rule:
- Gastric ulcer → biopsy (or repeat endoscopy to confirm healing and exclude malignancy)
- Duodenal ulcer → malignancy is rare; routine repeat scope not required if symptoms resolve
D. Stop NSAIDs and start a proton pump inhibitor ✅
Also know the next-step variations
- If the question stem adds high-risk bleeding stigmata on endoscopy (active bleeding, visible vessel, adherent clot):
→ endoscopic hemostasis + IV PPI - If unstable (shock, brisk bleed):
→ resuscitate + blood products + urgent endoscopy
E. Measure fasting serum gastrin level
Why it’s tempting: Gastrin = acid = ulcers. True… sometimes.
Why it’s wrong: No signs of Zollinger–Ellison syndrome (ZES).
- ZES clues:
- Multiple or refractory ulcers
- Ulcers in unusual locations (distal duodenum/jejunum)
- Chronic diarrhea/steatorrhea (acid inactivates pancreatic enzymes)
- MEN1 association (pituitary + parathyroid + pancreatic tumors)
High-yield physiology
- Gastrinoma → ↑ gastrin → parietal cell hyperplasia → ↑ acid → ulcers
- Diagnostic steps often include fasting gastrin and confirmatory testing (e.g., secretin stimulation in classic teaching), but Step questions mainly want you to recognize when to suspect it.
Rapid-Fire High-Yield PUD Pearls (Step 1 + Step 2)
Pathogenesis: Acid vs defense
- Duodenal ulcers: often ↑ acid load (commonly H. pylori increasing gastrin via decreased D-cell somatostatin)
- Gastric ulcers: often ↓ mucosal defenses (NSAIDs, impaired mucus barrier), acid may be normal/low
Complications you must recognize
- Bleeding: melena, anemia; most common complication
- Perforation: sudden severe abdominal pain, rigid abdomen, free air under diaphragm
- Penetration: pain radiating to back (posterior duodenal ulcer → pancreas)
- Gastric outlet obstruction: early satiety, vomiting, succussion splash (often from edema/scarring)
Medication associations
- NSAIDs: ulcers + gastritis (↓ prostaglandins)
- PPIs: best healing rates; long-term associations classically tested include ↓ Mg, ↓ B12, ↑ C. difficile risk (less Step 1, more clinical reasoning)
- Misoprostol (PGE₁ analog): prevents NSAID-induced ulcers (but causes diarrhea; contraindicated in pregnancy—uterotonic)
How to “Win” PUD Questions: A Quick Approach
- Localize (duodenal vs gastric) using meal relationship + endoscopy location.
- Identify the driver: NSAIDs vs H. pylori vs “refractory/multiple” (think ZES).
- Match management to risk:
- uncomplicated: remove cause + PPI
- H. pylori confirmed: eradicate + PPI
- high-risk bleed: endoscopic therapy + IV PPI
- gastric ulcer: biopsy / confirm healing to exclude cancer
Mini Table: Common “Distractor Traps” and What They Really Mean
| Distractor | What it’s actually testing | When it’s correct |
|---|---|---|
| Octreotide | Varices vs PUD bleed | Cirrhosis/portal HTN variceal hemorrhage |
| Antibiotic triple therapy | Not all ulcers are H. pylori | Confirmed H. pylori (or strong testing cue) |
| Repeat endoscopy for cancer | Gastric vs duodenal malignancy risk | Gastric ulcer follow-up/biopsy |
| Fasting gastrin | ZES recognition | Refractory/multiple ulcers + diarrhea, MEN1 |